11
Participants
Start Date
March 31, 2016
Primary Completion Date
June 13, 2018
Study Completion Date
June 13, 2018
Ibrutinib
Pomalidomide
Dexamethasone
Placebo
Concord Repatriation General Hospital, Concord
Princess Alexandra Hospital, Woolloongabba
'Alexandra' General Hospital of Athens, Athens
Virginia Commonwealth University, Richmond
Medical University of South Carolina, Charleston
Clinica Universidad de Navarra, Pamplona
Hospital Universitario de Salamanca, Salamanca
Cleveland Clinic, Cleveland
Hospital Universitario Doctor Peset, Valencia
City of Hope, Duarte
Dana-Farber Cancer Institute, Boston
Fakultni nemocnice Brno, Brno
Fakultni nemocnice Ostrava, Ostrava
Vseobecna fakultni nemocnice v Praze, Prague
Universitätsklinikum Carl Gustav Carus, Dresden
Hospital de La Santa Creu i Sant Pau, Barcelona
Lead Sponsor
Collaborators (1)
Celgene Corporation
INDUSTRY
Pharmacyclics LLC.
INDUSTRY